Items where authors include "Holmes, T."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Aad, G. orcid.org/0000-0002-6665-4934, Abbott, B. orcid.org/0000-0002-5888-2734, Abeling, K. orcid.org/0000-0002-1002-1652 et al. (5287 more authors) (2024) Evidence for the Higgs boson decay to a Z boson and a photon at the LHC. Physical Review Letters, 132 (2). 021803. ISSN 0031-9007

Pattem, J., Swift, T., Rimmer, S. et al. (3 more authors) (2021) Development of a novel micro-bead force spectroscopy approach to measure the ability of a thermo-active polymer to remove bacteria from a corneal model. Scientific Reports, 11. 13697. ISSN 2045-2322

Holmes, T., Brown, A.W., Suggitt, M. et al. (5 more authors) (2020) The influence of hypoxia and energy depletion on the response of endothelial cells to the vascular disrupting agent combretastatin A-4-phosphate. Scientific Reports, 10 (1). 9926. ISSN 2045-2322

Brown, A.W., Holmes, T., Fisher, M. et al. (3 more authors) (2018) Cover feature : Evaluation of sydnone-based analogues of Combretastatin A-4 phosphate (CA4P) as vascular disrupting agents for use in cancer therapy (ChemMedChem 24/2018). ChemMedChem, 13 (24). p. 2600. ISSN 1860-7179

Wright, A., Bandulasena, H., Ibenegbu, C. et al. (5 more authors) (2018) Dielectric barrier discharge plasma microbubble reactor for pretreatment of lignocellulosic biomass. AIChE Journal, 64 (11). pp. 3803-3816. ISSN 0001-1541

Harrity, J.P.A., Brown, A., Holmes, T. et al. (3 more authors) (2018) Evaluation of Sydnone-Based Analogs of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy. ChemMedChem. ISSN 1860-7179

This list was generated on Sat Apr 13 21:20:45 2024 BST.